KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Cisco Systems (CSCO) Research & Development (2016 - 2026)

Cisco Systems' Research & Development history spans 18 years, with the latest figure at $2.4 billion for Q1 2026.

  • On a quarterly basis, Research & Development rose 2.44% to $2.4 billion in Q1 2026 year-over-year; TTM through Jan 2026 was $9.5 billion, a 8.7% increase, with the full-year FY2025 number at $9.3 billion, up 16.5% from a year prior.
  • Research & Development hit $2.4 billion in Q1 2026 for Cisco Systems, down from $2.4 billion in the prior quarter.
  • Over the last five years, Research & Development for CSCO hit a ceiling of $2.4 billion in Q4 2025 and a floor of $1.7 billion in Q1 2022.
  • Historically, Research & Development has averaged $2.0 billion across 5 years, with a median of $2.0 billion in 2023.
  • Biggest five-year swings in Research & Development: fell 1.81% in 2022 and later increased 19.87% in 2025.
  • Tracing CSCO's Research & Development over 5 years: stood at $1.8 billion in 2022, then rose by 7.41% to $1.9 billion in 2023, then increased by 19.5% to $2.3 billion in 2024, then rose by 4.99% to $2.4 billion in 2025, then dropped by 1.88% to $2.4 billion in 2026.
  • Business Quant data shows Research & Development for CSCO at $2.4 billion in Q1 2026, $2.4 billion in Q4 2025, and $2.4 billion in Q3 2025.